The Valley Desk

NCT00240994 · Interventional trial

Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients

Overall registry status Completed

Phase 2

Conditions Immunosuppression, Kidney Failure, Chronic, Kidney Transplantation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov